Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 7, Pages -
Publisher
Springer Nature
Online
2018-07-03
DOI
10.1038/s41419-018-0804-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
- (2018) Fan Feng et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin
- (2018) Manel B. Hammouda et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity
- (2018) Jun Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma
- (2018) Markus Eberl et al. CANCER CELL
- Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
- (2018) Ling Li et al. CANCER CELL
- Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database
- (2018) Devalkumar J. Rajyaguru et al. JOURNAL OF CLINICAL ONCOLOGY
- A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma
- (2018) Hui Xie et al. OncoTargets and Therapy
- Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
- (2017) Petra C. Buchanan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
- (2017) Kim A. Reiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal
- (2017) Li An et al. PHARMACOLOGICAL RESEARCH
- Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
- (2017) Joseph Dosch et al. Oncotarget
- Current advances in the elimination of hepatitis B in China by 2030
- (2017) Shuye Zhang et al. Frontiers of Medicine
- A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
- (2016) W. M. Tai et al. ANNALS OF ONCOLOGY
- Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
- (2016) D. Koeberle et al. ANNALS OF ONCOLOGY
- Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents
- (2016) Hui Jia et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy
- (2016) Tzu-I Chao et al. CANCER LETTERS
- Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation
- (2016) Viola Lanier et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
- (2016) Karen T. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
- (2016) Nick Pavlakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Requirements for global elimination of hepatitis B: a modelling study
- (2016) Shevanthi Nayagam et al. LANCET INFECTIOUS DISEASES
- Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors
- (2016) Shuang Cao et al. MOLECULES
- Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
- (2016) Franck Madoux et al. Scientific Reports
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
- (2015) Yan Chen et al. CURRENT CANCER DRUG TARGETS
- Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
- (2015) Chunping Wang et al. HEPATOLOGY
- HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion
- (2015) Yingying Feng et al. Scientific Reports
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
- (2014) Benedek Gyöngyösi et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines
- (2013) JiHoon Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment
- (2013) Fan Yang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells
- (2008) L L Song et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started